BIO Welcomes Obama Commitment to Scientific Integrity

WASHINGTON, D.C. (Tuesday, March 10, 2009) - BIO President and CEO Jim Greenwood issued the following statement today in response to President Obama’s signing of a Presidential Memorandum on scientific integrity:


“President Obama’s commitment to scientific integrity in policymaking heralds an era of new possibilities for the U.S.   Biotechnology is uniquely positioned to fulfill the President’s vision of a robust science sector, capable of driving significant economic growth, providing advanced therapies and cures for patients suffering from debilitating diseases, developing new energy sources, and enhancing sustainable agriculture. 


“This is an important step to help continue America’s global leadership in innovation, particularly as emerging economies like China and India aggressively invest in science, including biotechnology.


“The commitment the President is making today will help to secure a cleaner, healthier, more prosperous future for our nation.  We in the life sciences are delighted to join him in that effort.”

Upcoming BIO Events

BIO-Europe Spring
March 16-18, 2009
Milan, Italy

BIO IP Counsels' Committee Conference
March 25–27, 2009
Phoenix, AZ

BIO National Venture Conference
March 31–April 1,2009
Boston, MA

BIO Windhover 2009
April 13-15, 2009
New York, NY

BIO-LES Business Development Basics Course
May 15–17, 2009
Atlanta, GA  

BIO-LES Advanced Business Development Course
May 15–17, 2009
Atlanta, GA 

BIO Executive Presentation Workshop
May 17, 2009
Atlanta, GA

BIO Human Resources Conference
May 17-19, 2009
Atlanta, GA

2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.

BioEquity Europe
June 9-10, 2009
Munich, Germany

World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada


About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.